Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Clinical trial NCT07227012 · RECRUITING

Trial details

NCT number: NCT07227012
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular Hepatocellular Cancer Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma Liver Neoplasms Advanced Hepatocellular Carcinoma Metastatic Hepatocellular Carcinoma

Start date: 2025-12-01
Primary completion: 2027-10-18
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.